loader
Please Wait
Applying Filters...
menu
    • menu

    List of Certificates of Suitability (CEPs) for r1_cep_2003_242___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Società Generale per l'Industria della Magnesia S.p.A

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Società Generale per l'Industria della Magnesia S.p.A. Angera (Va) IT

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Società Generale per l'Industria d...

    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag Italy
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Calcium carbonate

      Portfolio PDF

      Product Web Link

      Virtual Booth

      Digital Content

      Website

      Corporate PDF

      R1-CEP 2003-242 - Rev 00
      Valid
      Chemical
      2009-07-20
      14
      blank

      01

      Società Generale per l'Industria d...

      Italy
      BioProcess International
      Not Confirmed
      arrow

      Società Generale per l'Industria d...

      Italy
      arrow
      BioProcess International
      Not Confirmed
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag Italy
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Calcium carbonate

      Certificate Number : R1-CEP 2003-242 - Rev 00

      Status : Valid

      Issue Date : 2009-07-20

      Type : Chemical

      Substance Number : 14

      blank

      Portfolio PDF

      Product Web Link

      Virtual Booth

      Digital Content

      Website

      Corporate PDF

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-242 - Rev 00 of Società Generale Per L'industria Della Magnesia S.p.a. Angera (va) It

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-242 - Rev 00 of Società Generale Per L'industria Della Magnesia S.p.a. Angera (va) It 1

      20

      Società Generale Per L'industria Della Magnesia S.p.a. Angera (va) It, based in Italy, is a pharmaceutical company.

      One of their significant offerings is Calcium carbonate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-242 - Rev 00

      This Chemical Type CEP, issued on July 20, 2009, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

      Substance Number 14 associated with this CEP further emphasizes